Regulation of inflammatory responses by MAPK signal transduction pathways

( views:, downloads: )
JIANG Yong()
GONG Xiao-Wei()
Journal Title:
Volume 52, Issue 04, 2000
Key Word:


  • [1]Jiang Y(姜勇), Liu AH(刘爱华), Zhao KS(赵克森). The signal transduction pathways of mitogen-activated protein kinase. J First Mil Med Univ(第一军医大学学报), 1999, 19(1): 59~62(in Chinese).
  • [2]Zhang L(张璐), Jiang Y(姜勇), Zhang L(张琳) et al. Progress of study on mitogen-activated protein kinase. Foreign Med Sci: Section Pathophysiol Clin Med(国外医学: 生理、病理科学与临床分册), 1999, 19(2): 84~87(in Chinese).
  • [3]Jiang Y(姜勇), Han JH(韩家淮). P38 MAPK signal transduction pathway. Chin Bull Life Sci(生命科学), 1999, 11(3): 102~106(in Chinese).
  • [4]Zhang L(张璐), Zhang L(张琳), Jiang Y(姜勇) et al. The role of mitogen-activated protein kinases in cell apoptosis. Chem Life(生命的化学), 1998, 18(4): 16~18(in Chinese).
  • [5]Jiang Y(姜勇). Progress of study on the mechanism of activation of endothelial cells induced by lipopolysaccharide. Natl Med J China(中华医学杂志), 1999, 79(1): 76~78(in Chinese).
  • [6]Jiang Y(姜勇), Ulevitch RJ. The signal transduction of cell activation by LPS: The studies from CD14 to p38 MAPK. Prog Physiol Sci(生理科学进展), 1999, 30(1): 29~34(in Chinese with English abstract).
  • [7]Jiang Y, Chen C, Li Z et al. Characterization of the struc~ture and function of a new mitogen-activated protein kinase(p38β). J Biol Chem, 1996, 271(30): 17920~17926.
  • [8]Jiang Y, Gram H, Padova FD et al. Characterization of the structure and junction of the fourth member of p38 group MAP kinases-p38δ. J Biol Chem, 1997, 272(48): 30122~30128.
  • [9]New L, Jiang Y, Zhao M et al. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J, 1998, 17(12): 3372~3384.
  • [10]Dziarske R, Jin YP, Gupta D. Differential activation of extracellular signal-regulated kinase(ERK)1, ERK2, p38 and c-Jun N-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. J Infect Dis, 1996, 174(4): 777~785.
  • [11]Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem, 1996, 271(40): 24313~24316.
  • [12]Han J, Lee JD, Bibbs L et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science, 1994, 265(5173): 808~811.
  • [13]Lee JC, Laydon JT, McDonnell PC et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 1994, 372(6508): 739~746.
  • [14]Li Z, Jiang Y, Ulevitch RJ et al. The primary structure of p38γ: a new member of p38 group of MAP kinase. Biochem Biophys Res Commun, 1996, 228(2): 334~340.
  • [15]Hale KK, Trollinger D, Rihanek M et al. Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma and delta in inflammatory cell lineages. J Immunol, 1999, 162(7): 4246~4252.
  • [16]Jiang Y(姜勇), Liu AH(刘爱华), Huang QB(黄巧冰)et al. p38 MAPK signal is necessary for TNF-α gene expression in RAW cells. Acta Biochim Biophys Sin(生物化学与生物物理学报), 1999, 31(1): 9~15.
  • [17]Jiang Y(姜勇), Liu AH(刘爱华), Zhang L(张琳)et al. Activation of p38 mitogen-activated protein kinase induced by lipopolysaccharide and its role in TNF-α gene expression. J Med Coll PLA, 1999, 14(2): 138~143(in Chinese).
  • [18]Han J, Jiang Y, Li Z et al. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature, 1997, 386(6622): 296~299.
  • [19]English JM, Pearson G, Baer R et al. Indentification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases. J Biol Chem, 1998, 273(7): 3854~3860.
  • [20]Zhao M(赵明), Liu YW(刘亚伟), Liu AH(刘爱华)et al. Signal transduction in TNF-α inducted c-jun gene expression. Acta Biochim Biophys Sin(生物化学与生物物理学报), 2000, 32(3): 59~65(in Chinese with English abstract).
  • [21]Guan Z, Baier LD, Morrison AR. P38 mitogen-activated protein kinase down-regulates nitric oxide and up regulates prostaglandin E2 biosynthesis stimulated by interleukin-1 beta. J Biol Chem, 1997, 272(12): 8083~8089.
  • [22]Adderley SR, Fitzgerald DJ. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem, 1999, 274(8): 5038~5046.
  • [23]Guan Z, Buckman SY, Miller BW et al. Interleukin-1 beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal messangial cells. J Biol Chem, 1998, 273(44): 28670~28676.
  • [24]Read MA, Whitley MZ, Gupta S et al. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-Kappa B and c-Jun N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem, 1997, 272(5): 2753~2761.
  • [25]Bruder JT, Kovesdi T. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol, 1997, 71(1): 398~404.
  • [26]Lee JC, Kassis S, Kumar S et al. p38 mitogen-activated protein kinase inhibitors-mechanisms and therapeutic potentials. Pharmacol Ther, 1999, 82(2-3): 389~397.
  • [27]Jiang Y, Li Z, Schwarz EM et al. Structure-function studies of p38 mitogen-activated protein kinase. Loop 12 influences substrate specificity and autophosphorylation, but not upstream kinase selection. J Biol Chem, 1997, 272(7): 11096~11102.
  • [28]Lisnock J, Tebben A, Frantz B et al. Molecular basis for p38 protein kinase inhibitor specificity. Biochemistry, 1998, 37(47): 16573~16581.
  • [29]Dumont FJ, Staruch MJ, Fischer P et al. Inhibition of T cell activated by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J Immunol, 1998, 160(6): 2579~2589.
  • [30]Badger AM, Bradbeer JN, Votta B et al. Pharmacological profile of SB203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther, 1996, 279(3): 1453~1461.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615